Aripiprazole

Aripiprazole: Recognising Inner Restlessness & What Sets It Apart from Other Antipsychotics

Aripiprazole is an atypical antipsychotic and acts as a partial agonist at the dopamine receptor: it dampens the signal where too much dopamine is about, and activates it where too little arrives. From that follows a side effect profile that differs markedly from older substances and from other atypical ones. The typical side effect is not tiredness but an agonising inner restlessness.

See more detail

Keep an eye on aripiprazole and on how you feel

Record your doses, your restlessness and your sleep over the weeks — free in the brite app.

Track aripiprazole

1. At a Glance: Technical Data Sheet

PropertyDetails
Active ingredientAripiprazole
ATC codeN05AX12
Drug classAtypical antipsychotic; partial agonist at the dopamine D2 receptor (a “dopamine stabiliser”)
Dosage formsTablets and orodispersible tablets (usually 5 to 30 mg), oral solution, depot injection given monthly
Half-lifeAround 75 hours, and longer still for the active breakdown product — a stable blood level is only reached after about two weeks
Maximum daily dose30 mg according to the SmPC; your individual dose is set by the treating practice
Onset of effectFirst effects often after a few days; a full assessment takes several weeks
MetabolismVia the liver enzymes CYP2D6 and CYP3A4 — hence the relevant interactions
Prescription statusPrescription-only medicine
Notable featureLittle sedation and a more favourable metabolic profile than many other atypical antipsychotics; the typical side effect is inner restlessness (akathisia)
Table scrolls to the right

2. How it works: what a partial agonist does differently

Most antipsychotics block the dopamine D2 receptor completely: they switch the signal off. Aripiprazole does something else. It binds to the same receptor, but triggers a weakened signal there. That is called partial agonism.¹

The effect depends on how much of the body's own dopamine is about at the time:

  • Too much dopamine — for example in the brain pathways that are overactive in psychosis: aripiprazole displaces the stronger signal and acts as a damper.
  • Too little dopamine — for example in pathways responsible for drive and motivation: there aripiprazole supplies a residual signal and acts more as an activator.

Aripiprazole also acts at serotonin receptors, which contributes to its effect on mood. From this mechanism follow the three properties that shape everyday life: less sedation than with strongly dampening substances, less of a rise in prolactin — and, as the flip side, a marked tendency towards inner restlessness. Anyone expecting a calming effect often experiences the opposite here.

Why the long half-life matters. At around 75 hours, aripiprazole is one of the very long-acting substances. That means two things: a single missed dose carries less weight — and every change of dose only shows its full effect after about two weeks. Judge after three days and you judge too early, in both directions.

3. When aripiprazole is used

Aripiprazole is used in several psychiatric conditions. In Germany it is licensed above all for the treatment of schizophrenia, as well as for moderate to severe manic episodes in bipolar disorder and to prevent new manic episodes.¹,²

A question that comes up often is its use in depression. Precision is worth it here: internationally, aripiprazole has been studied as an add-on medicine alongside an antidepressant where the antidepressant alone does not work well enough. In Germany, however, aripiprazole is not licensed for this add-on treatment; using it this way is off-label use in the individual case and has to be discussed explicitly. Among the substances licensed here as an add-on in depression is quetiapine.³

Whether and when such an extension makes sense is always decided by the treating practice or clinic — together with you and on the basis of the guidelines.


4. Dosing and the depot injection

The figures below describe what the SmPC gives as the usual approach. They are not a dosing instruction.

  • Starting dose: it varies with the condition and the situation; for add-on treatment the starting point is considerably lower than for a psychosis.
  • Increases: because of the long half-life, usually at intervals of at least one to two weeks.
  • Maximum dose: 30 mg daily according to the SmPC.
  • An adjustment is needed in known CYP2D6 “poor metabolisers” and with certain concomitant medicines — see section 9.

The depot injection. Aripiprazole is also available as a depot injection, given into the muscle as a rule once a month. The advantage is obvious: no daily tablet, nothing to forget, an even blood level. So is the drawback: if a side effect appears, it cannot be cut short by leaving out the next tablet — the drug stays in the body for weeks. Before switching to a depot, it is therefore checked whether the substance was tolerated as a tablet.


5. Taking it: time of day, meals, missed doses

  1. Usually in the morning. Because aripiprazole is more activating than dampening, it is often taken in the morning. Taking it in the evening can make falling asleep harder.
  2. Meals make no difference. You can take the tablet with or without food; absorption is not meaningfully changed by it.
  3. Orodispersible tablets disintegrate on the tongue and need no water — helpful with swallowing problems or where dosing is supervised.
  4. Missed dose: because of the long half-life, a single missed tablet carries less weight than with short-acting medicines. A double amount the next day is still not the answer. The general points are covered in the guide missed a medication.
  5. Change nothing on your own. Neither the dose nor the timing nor breaks in treatment — that applies particularly to this substance, because changes only show up weeks later.
The most important tip for the first few weeks: write it down. Restlessness, sleep, drive and mood change slowly and unevenly on aripiprazole. A short daily note — two lines will do — makes the difference at your next appointment between “somehow odd” and an observation you can rely on.

Record your restlessness, your sleep and your doses

So that at your next appointment it is clear when what started.

Start a health log

6. Side effects and what helps against them

Aripiprazole is regarded as comparatively well tolerated — but “tolerated differently” puts it better. The typical complaints differ markedly from those of strongly dampening substances.

Commoner, mostly in the first few weeks

  • Inner restlessness and an urge to move (akathisia) — the characteristic side effect, covered in detail in the next section.
  • Sleep problems — caused by the activating component; moving the dose to the morning often improves matters.
  • Nausea, vomiting, constipation — usually temporary and strongest in the first few days.
  • Headache, dizziness — particularly on standing up, because blood pressure can dip briefly.
  • Tremor and muscle stiffness — rarer than with older substances, but possible; persistent trembling should be raised.

Rarer, but worth knowing about

  • Impulse control disorders — gambling, compulsive shopping, binge eating, increased sexual drive; see section 8.
  • Tardive dyskinesia — involuntary movements, above all in the face, which can appear after longer treatment. The risk is lower than with older antipsychotics, but it is not zero.
  • Metabolic changesweight gain and rises in blood sugar and blood lipids. They occur less often on aripiprazole than on other atypical antipsychotics, but they are not ruled out; that is why they are monitored.
  • Seizures and changes in the blood count — rare, but a reason for medical checks.
Seek medical help immediately. A high fever with pronounced muscle stiffness, confusion, heavy sweating and a racing pulse raises the suspicion of neuroleptic malignant syndrome — that is an emergency, call 112 (emergency services in Germany). Also have this investigated straight away: newly arising thoughts of suicide. You can report unusual reactions afterwards, see side effects of medications.

7. Akathisia: recognising and naming inner restlessness

If there is one side effect you have to know about with aripiprazole, this is it. Akathisia (restlessness that makes sitting still impossible) is an agonising feeling of being inwardly driven, coupled with an urge to move. It typically appears in the first days to weeks and after every increase in dose.¹,²

The real problem is not how often it happens but how easily it is mistaken for something else: akathisia is regularly read as anxiety, as nervousness or as a worsening of the underlying illness. The obvious response — raising the dose — then makes it worse. Knowing the signs lets you prevent that.

How to recognise akathisia

  • The urge comes from the body, not from your thoughts: it feels physical, an inability “to sit still” — unlike worried rumination.
  • Visible signs: constant jiggling of the legs, marching on the spot while standing, pacing up and down, shifting weight from one foot to the other, getting up in the middle of a conversation.
  • Moving brings brief relief, while sitting still makes it worse at once.
  • The timing fits: it starts shortly after treatment begins, after a dose increase or after a switch to a depot.
  • Different from restless legs syndrome: akathisia affects the whole body and is not confined to the evening.

For the general picture of this symptom — and which other causes come into question — see the article on inner restlessness.

The sentence that helps in the consulting room. Do not say “I am getting worse”, say: “Since the dose increase I physically cannot sit still any more, I have to keep getting up and walking — it feels different from my anxiety.” That names akathisia, and the practice can respond in a targeted way: with a dose reduction, a slower increase, a specific counter-medicine or a change of substance. What you should not do is stop on your own — see stopping medications.

8. Impulse control disorders: the side effect nobody knows about

This side effect is rare, but it can cost people their livelihood — and hardly anyone expects it. On aripiprazole, a newly arising or markedly increased urge to give in to certain impulses has been described. The authorities have therefore added an explicit warning to the product information.

Relatives should know about this too. What has been reported includes pathological gambling (games of chance, sports betting, online casinos), compulsive shopping, binge eating and an increased sexual drive, extending to risky behaviour. Those affected often do not recognise the change as a side effect at all — they experience it as their own wish. It therefore makes sense to let someone you trust in on it and to raise the question actively at your check-up appointments. If something like this appears: do not wait, do not stop on your own, but inform the treating practice promptly. As a rule the impulses recede once the dose is reduced or the treatment changed. See also side effects of medications.

Warning signs in everyday life are secret movements on bank accounts, new accounts or loans, online activity that is kept quiet, sudden activity at night and unusual spending. This is not a weakness of character and not a relapse into mania — it can be an effect of the medicine, and that is exactly how it should be discussed.


9. Interactions: CYP2D6, CYP3A4, alcohol

Aripiprazole is broken down by two liver enzymes: CYP2D6 and CYP3A4. Anything that slows these enzymes down or revs them up changes the blood level — upwards with more side effects, downwards with a loss of effect.

CombinationConsequenceWhat to do
Strong CYP2D6 inhibitors (e.g. certain antidepressants such as fluoxetine or paroxetine)Aripiprazole levels rise, with more restlessness and more side effectsDose adjustment by the practice; plan the combination deliberately
Strong CYP3A4 inhibitors (e.g. certain antifungals and macrolide antibiotics)Levels rise markedlyThe dose is usually reduced for as long as the combination runs
CYP3A4 inducers (e.g. carbamazepine, St John's wort)Levels fall and the effect can be lostNever add St John's wort on your own; checking back is a must
Grapefruit and grapefruit juiceCan inhibit the breakdown via CYP3A4Avoid it or clarify with your pharmacy, see grapefruit and medications
Other sedating agents, sleeping tablets, opioidsIncreased tiredness and risk of fallsCombine only after consultation
AlcoholIncreases drowsiness and impairs judgement, and can destabilise the underlying illnessBest avoided, see medications and alcohol
Table scrolls to the right

Some people break aripiprazole down more slowly for genetic reasons (“poor CYP2D6 metabolisers”). For them the SmPC provides for a reduced dose. Check new combinations in the guide drug interactions or directly in the interaction check in the brite app — particularly if several specialties are prescribing for you (polypharmacy).

Driving while the dose is being settled. Aripiprazole makes you tired less often than strongly dampening substances, but it can impair concentration, reactions and vision — above all at the start and after changes of dose. Only drive again once you feel safe and have discussed it with your practice: medications and driving.

10. Aripiprazole compared with other antipsychotics

All atypical antipsychotics act on the dopamine and serotonin systems, but they differ markedly in their side effect profiles. The decisive question is not “stronger” or “weaker” but: which side effect can you most readily live with?²

FeatureAripiprazoleOther atypical antipsychotics by comparison
SedationLow — it can even disturb sleep at firstOlanzapine and quetiapine are markedly more dampening
Weight and metabolismMore favourable, but not neutralOlanzapine is regarded as the hardest on metabolism in the group
ProlactinTends to fall — cycle disturbances and milk flow are rarerRisperidone and amisulpride typically make prolactin rise
Inner restlessness (akathisia)Markedly commoner — that is the price of partial agonismRarer with dampening substances
Dosage formsTablet, orodispersible tablet, oral solution, monthly depotDepot forms exist for several other substances too
Table scrolls to the right

In bipolar disorder, aripiprazole is often combined with mood stabilisers such as lithium or lamotrigine; in the treatment of depression an antidepressant such as sertraline usually comes first. Which combination fits depends on the course of the illness, on previous experience and on tolerability — and it is a decision for the treating practice, not for the internet.


11. Special situations: stopping, older age, pregnancy

Never stop abruptly

Aripiprazole is not addictive — stopping abruptly is still not a good idea. Two things can happen: discontinuation phenomena such as restlessness, insomnia, nausea and sweating, and above all a relapse of the underlying illness, often with weeks of delay. Because of the long half-life the blood level falls slowly, so that the connection is barely recognisable later on. A planned, step-by-step taper with appointments and an emergency plan is therefore the safe route: stopping medications.

In older age

In older people the dose is lower, because dizziness, drops in blood pressure and falls are more common. One special warning matters: in older people with dementia, antipsychotics as a group are associated with increased mortality and an increased risk of stroke. Aripiprazole is not licensed for treating behavioural problems in dementia. The guide medications in old age gives you your bearings on the subject.¹

Pregnancy and breastfeeding

Do not stop on your own — but do discuss it. There is less experience with aripiprazole than with some older substances. Where it is used in the final third of pregnancy, adaptation problems in the newborn with restlessness, trembling or poor feeding are possible. But a severe mental illness left untreated is also a considerable risk in pregnancy — weighing that up belongs in experienced hands. You will find current assessments at Embryotox; for general orientation see the guide medications during pregnancy.

12. Aripiprazole experiences: what patients really ask

“Since the switch I am constantly on the move — is that the illness or the medicine?”

That is the commonest and the most important question with this substance. A good clue is the timing: if the restlessness began within days of starting treatment or of a dose increase, much speaks for akathisia. A second clue is the quality: akathisia feels physical and forces you to move, whereas anxiety tends to circle in your thoughts. The two can overlap. Note down when it started, the time of day and any connection with changes of dose — and bring those notes with you. That is exactly what a health log is for.

“I have been sleeping badly since starting aripiprazole — should I take it in the evening?”

Usually the opposite is right. Because the substance is more activating, it is often moved to the morning. But do not change the time on your own; raise it instead — not least because sleep problems in mental illness can have several causes. What else helps is set out in the guide sleeping pills: what really helps?.

“Will I put on weight?”

It is less likely than with some other atypical antipsychotics — but it happens. It makes sense to have your weight, blood sugar and blood lipids checked before treatment starts and then regularly, rather than reacting once ten kilos are on. Exercise and a deliberate eating routine work preventively here, not just as repair work.

“Can I stop if I am doing well?”

That you are doing well is often the result of the treatment. After a psychosis or a manic episode in particular, the risk of relapse after stopping is considerable, and because of the long half-life the relapse often comes only after weeks — at which point it looks like coincidence. If you want to stop, that is a legitimate goal: planned, slow, supported and with a plan for emergencies.

Adding a new medicine? Check it first.

The interaction check shows what shifts your aripiprazole levels.

Check the combination

FAQ: Common questions about aripiprazole

First effects often show after a few days, but because of the long half-life a stable blood level is only reached after about two weeks. That is why the dose is usually not increased faster than that. A judgement you can rely on takes several weeks.
Akathisia is an agonising inner restlessness with a physical urge to move. Typical are jiggling legs, marching on the spot, pacing up and down and being unable to sit still. It usually begins shortly after treatment starts or after a dose increase and eases briefly with movement. It is often mistaken for anxiety or a worsening of the illness and should therefore be raised explicitly.
Less often than many other antipsychotics. Aripiprazole is more activating, which is why it is frequently taken in the morning. Some people still get tired on it. Sleep problems at the start, by contrast, are typical and often improve once the dose is moved to the earlier part of the day.
Yes, impulse control disorders are among the known, if rare, side effects. What has been described includes pathological gambling, compulsive shopping, binge eating and an increased sexual drive. Those affected often do not experience it as a side effect. That is why relatives should be informed, and why any change belongs in the consulting room promptly rather than leading to stopping on your own.
Aripiprazole is regarded as easier on metabolism than several other atypical antipsychotics, but it is not weight-neutral. Checks of weight, blood sugar and blood lipids are recommended before treatment starts and then at regular intervals. Exercise and a settled eating routine work better as prevention than late counter-measures do.
Alcohol increases drowsiness and impairs judgement, and it can destabilise mental illness. That is why it is advised against. If you do drink, speak about it openly rather than keeping it quiet, because the combination also affects how effects and side effects are judged.
The depot is given into the muscle as a rule once a month and provides an even blood level without a daily tablet. The drawback is that it is harder to steer: if a side effect appears, the drug stays in the body for weeks. That is why it is checked beforehand whether aripiprazole was tolerated as a tablet.
No. Aripiprazole is not addictive, but an abrupt end clearly raises the risk of relapse, and discontinuation phenomena such as restlessness or insomnia are possible. Because of the long half-life a relapse often only appears after weeks. An attempt to stop should be planned, taken step by step and medically supported.

Sources

  1. Summary of Product Characteristics (SmPC) for aripiprazole (current version, available through the information system of the licensing authorities). pharmnet-bund.de
  2. S3 guideline on schizophrenia (DGPPN, AWMF reg. no. 038-009) — German source. awmf.org
  3. German National Care Guideline on unipolar depression (BÄK, KBV, AWMF, reg. no. nvl-005) and S3 guideline on bipolar disorders (DGBS/DGPPN, AWMF reg. no. 038-019) — German source. awmf.org
  4. BfArM (Germany's federal institute for drugs and medical devices) and EMA: product information and safety notices on aripiprazole, among them those on impulse control disorders. bfarm.de
  5. Embryotox, Charité — German pharmacovigilance and advisory centre on embryonic toxicology: aripiprazole in pregnancy and breastfeeding. Accessed 2026. embryotox.de
  6. Gesundheitsinformation.de (IQWiG): Treatment of schizophrenia and bipolar disorders. Accessed 2026 — German source. gesundheitsinformation.de

Support for everyday life on aripiprazole — with brite

Record your doses, your restlessness and your sleep, and show them at your appointment. Free.

Create medication plan
brite App
Medical disclaimer: This article is for general information and does not replace medical advice, diagnosis or treatment. Never stop aripiprazole abruptly and never stop it on your own — the risk of relapse is considerable and often only shows itself after weeks. With agonising inner restlessness, with newly arising impulse control disorders such as an urge to gamble or to shop, with a high fever and muscle stiffness, or with thoughts of suicide, contact your treating practice immediately or, in an emergency, call 112 (emergency services in Germany). The choice of medicine and the dose are always set individually by the treating practice. Last updated: August 2026.